Tokyo, Japan

Sachio Nomura

This inventor holds 1 USPTO granted patent. Top assignees: Japanese Foundation for Cancer Research, Sekisui Medical Co., Ltd.. Active years: 2021.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sachio Nomura: Innovator in Tumor Determination Methods

Introduction

Sachio Nomura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of methods for tumor determination. His innovative approach aims to enhance the accuracy of tumor diagnosis, which is crucial for effective treatment.

Latest Patents

Nomura holds a patent for a tumor determination method. This method is designed to provide a reliable way to identify tumors by analyzing genomic DNA from patient tissues or cells. The process involves treating the DNA with bisulfite, amplifying specific regions, and using ion exchange chromatography to detect methylation patterns. This innovative technique allows for the determination of tumors derived from patients without Lynch syndrome, thereby improving diagnostic precision.

Career Highlights

Throughout his career, Sachio Nomura has worked with esteemed organizations such as the Japanese Foundation for Cancer Research and Sekisui Medical Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer diagnostics.

Collaborations

Nomura has collaborated with notable colleagues, including Masami Arai and Yuriko Nemoto. These partnerships have facilitated the exchange of ideas and expertise, further advancing the field of tumor determination.

Conclusion

Sachio Nomura's contributions to cancer research through his innovative tumor determination method highlight his role as a key inventor in the medical field. His work continues to impact the accuracy of cancer diagnostics, ultimately benefiting patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…